Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Winner

Teva Pharmaceutical Industries ( TEVA) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.3%. By the end of trading, Teva Pharmaceutical Industries rose $0.42 (1.1%) to $39.20 on average volume. Throughout the day, 3,461,521 shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 3,814,400 shares. The stock ranged in a price between $38.74-$39.38 after having opened the day at $38.74 as compared to the previous trading day's close of $38.78. Other companies within the Health Care sector that increased today were: Halozyme Therapeutics ( HALO), up 24.8%, Enzon Pharmaceuticals ( ENZN), up 15.6%, Ventrus Biosciences ( VTUS), up 14.8% and StemCells ( STEM), up 14.6%.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. Teva Pharmaceutical Industries has a market cap of $32.9 billion and is part of the drugs industry. The company has a P/E ratio of 17.5, below the S&P 500 P/E ratio of 17.7. Shares are up 3.9% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Teva Pharmaceutical Industries a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Teva Pharmaceutical Industries as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Senesco Technologies ( SNTI), down 77.9%, Pingtan Marine Enterprise ( PME), down 58.0%, Mast Therapeutics ( MSTX), down 41.5% and IsoRay ( ISR), down 18.6% , were all laggards within the health care sector with Eli Lilly and Company ( LLY) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

CEOs Are Dropping Like Flies

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

S&P 500 and Dow Aim for New Records With Broad-Based Gains Ahead of Fed

Dow and S&P 500 Reach New Intraday Highs With Markets in Good Mood Ahead of Fed